{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T17:54:47Z","timestamp":1784570087590,"version":"3.55.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Histochemica"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.acthis.2022.151991","type":"journal-article","created":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T21:46:48Z","timestamp":1671659208000},"page":"151991","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Highly expressed FYN promotes the progression of placenta accreta by activating STAT3, p38, and JNK signaling pathways"],"prefix":"10.1016","volume":"125","author":[{"given":"Miao","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlong","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangxi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangxiang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8226-1949","authenticated-orcid":false,"given":"Fengge","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongmei","family":"Man","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.acthis.2022.151991_bib1","article-title":"Systematic identification of hub genes in placenta accreta spectrum based on integrated transcriptomic and proteomic analysis","volume":"11","author":"Chen","year":"2020","journal-title":"Front. Genet."},{"key":"10.1016\/j.acthis.2022.151991_bib2","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.placenta.2020.09.068","article-title":"Serum miRNA biomarker discovery for placenta accreta spectrum","volume":"101","author":"Chen","year":"2020","journal-title":"Placenta"},{"key":"10.1016\/j.acthis.2022.151991_bib3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3390\/cancers11050731","article-title":"STAT3: a promising therapeutic target in multiple myeloma","volume":"11","author":"Chong","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.acthis.2022.151991_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.597549","article-title":"CCN3 signaling is differently regulated in placental diseases preeclampsia and abnormally invasive placenta","volume":"11","author":"Duan","year":"2020","journal-title":"Front Endocrinol."},{"key":"10.1016\/j.acthis.2022.151991_bib5","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.phrs.2015.08.010","article-title":"Fyn is an important molecule in cancer pathogenesis and drug resistance","volume":"100","author":"Elias","year":"2015","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.acthis.2022.151991_bib6","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-017713","article-title":"Incidence, risk factors and perinatal outcomes for placenta accreta in Australia and New Zealand: a case-control study","volume":"7","author":"Farquhar","year":"2017","journal-title":"Bmj Open"},{"key":"10.1016\/j.acthis.2022.151991_bib7","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.placenta.2020.01.004","article-title":"Trophoblast invasion: lessons from abnormally invasive placenta (placenta accreta)","volume":"102","author":"Illsley","year":"2020","journal-title":"Placenta"},{"issue":"3","key":"10.1016\/j.acthis.2022.151991_bib8","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/ijgo.12407","article-title":"FIGO consensus guidelines on placenta accreta spectrum disorders: epidemiology","volume":"140","author":"Jauniaux","year":"2018","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"1","key":"10.1016\/j.acthis.2022.151991_bib9","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ajog.2017.05.067","article-title":"Placenta accreta spectrum: pathophysiology and evidence-based anatomy for prenatal ultrasound imaging","volume":"218","author":"Jauniaux","year":"2018","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"10","key":"10.1016\/j.acthis.2022.151991_bib10","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1158\/1078-0432.CCR-10-1264","article-title":"Fyn is downstream of the HGF\/MET signaling axis and affects cellular shape and tropism in PC3 cells","volume":"17","author":"Jensen","year":"2011","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.acthis.2022.151991_bib11","doi-asserted-by":"crossref","first-page":"86","DOI":"10.5603\/GP.2019.0015","article-title":"Expression of Cripto-1 in the placenta and its role in placenta accreta and placenta previa","volume":"90","author":"Jiang","year":"2019","journal-title":"Ginekol. Pol."},{"issue":"1","key":"10.1016\/j.acthis.2022.151991_bib12","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3892\/ijo.2017.4018","article-title":"Fyn\/heterogeneous nuclear ribonucleoprotein E1 signaling regulates pancreatic cancer metastasis by affecting the alternative splicing of integrin beta1","volume":"51","author":"Jiang","year":"2017","journal-title":"Int. J. Oncol."},{"issue":"4","key":"10.1016\/j.acthis.2022.151991_bib13","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrclinonc.2018.8","article-title":"Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer","volume":"15","author":"Johnson","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"48","key":"10.1016\/j.acthis.2022.151991_bib14","doi-asserted-by":"crossref","first-page":"46085","DOI":"10.1074\/jbc.M208138200","article-title":"Fyn and p38 signaling are both required for maximal hypertonic activation of the osmotic response element-binding protein\/tonicity-responsive enhancer-binding protein (OREBP\/TonEBP)","volume":"277","author":"Ko","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.acthis.2022.151991_bib15","doi-asserted-by":"crossref","first-page":"456","DOI":"10.4062\/biomolther.2020.013","article-title":"Dasatinib inhibits Lyn and Fyn Src-family kinases in mast cells to suppress type I hypersensitivity in mice","volume":"28","author":"Lee","year":"2020","journal-title":"Biomol. Ther."},{"issue":"1","key":"10.1016\/j.acthis.2022.151991_bib16","first-page":"23","article-title":"Research on the expression of MRNA-518b in the pathogenesis of placenta accreta","volume":"23","author":"Long","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol."},{"issue":"5","key":"10.1016\/j.acthis.2022.151991_bib17","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1111\/jcmm.14990","article-title":"The expression and biological function of chemokine CXCL12 and receptor CXCR4\/CXCR7 in placenta accreta spectrum disorders","volume":"24","author":"Long","year":"2020","journal-title":"J. Cell Mol. Med."},{"issue":"9","key":"10.1016\/j.acthis.2022.151991_bib18","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/j.cellsig.2005.11.005","article-title":"Fyn kinase acts upstream of Shp2 and p38 mitogen-activated protein kinase to promote chemotaxis of mast cells towards stem cell factor","volume":"18","author":"Samayawardhena","year":"2006","journal-title":"Cell Signal."},{"issue":"16","key":"10.1016\/j.acthis.2022.151991_bib19","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1056\/NEJMcp1709324","article-title":"Placenta accreta spectrum","volume":"378","author":"Silver","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.acthis.2022.151991_bib20","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1186\/s12935-020-01336-2","article-title":"A novel chalcone derivative suppresses melanoma cell growth through targeting Fyn\/Stat3 pathway","volume":"20","author":"Tang","year":"2020","journal-title":"Cancer Cell Int."},{"issue":"34","key":"10.1016\/j.acthis.2022.151991_bib21","doi-asserted-by":"crossref","first-page":"31574","DOI":"10.1074\/jbc.M303499200","article-title":"Src kinases mediate STAT growth pathways in squamous cell carcinoma of the head and neck","volume":"278","author":"Xi","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"46","key":"10.1016\/j.acthis.2022.151991_bib22","doi-asserted-by":"crossref","first-page":"74612","DOI":"10.18632\/oncotarget.11916","article-title":"Fyn phosphorylates AMPK to inhibit AMPK activity and AMP-dependent activation of autophagy","volume":"7","author":"Yamada","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.acthis.2022.151991_bib23","volume":"26","author":"Yang","year":"2020","journal-title":"Med. Sci. Monit."},{"issue":"8","key":"10.1016\/j.acthis.2022.151991_bib24","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/s41419-020-02830-1","article-title":"FYN is required for ARHGEF16 to promote proliferation and migration in colon cancer cells","volume":"11","author":"Yu","year":"2020","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.acthis.2022.151991_bib25","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11060-012-0933-1","article-title":"FRK controls migration and invasion of human glioma cells by regulating JNK\/c-Jun signaling","volume":"110","author":"Zhou","year":"2012","journal-title":"J. Neurooncol."},{"issue":"6","key":"10.1016\/j.acthis.2022.151991_bib26","first-page":"3862","article-title":"Galectin-1 induces metastasis and epithelial-mesenchymal transition (EMT) in human ovarian cancer cells via activation of the MAPK JNK\/p38 signalling pathway","volume":"11","author":"Zhu","year":"2019","journal-title":"Am. J. Transl. Res."},{"issue":"11","key":"10.1016\/j.acthis.2022.151991_bib27","doi-asserted-by":"crossref","first-page":"3824","DOI":"10.1016\/j.bbadis.2018.09.007","article-title":"Sphingosine kinase 2 cooperating with Fyn promotes kidney fibroblast activation and fibrosis via STAT3 and AKT","volume":"1864","author":"Zhu","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."}],"updated-by":[{"DOI":"10.1016\/j.acthis.2023.151996","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000}}],"container-title":["Acta Histochemica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065128122001507?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065128122001507?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,24]],"date-time":"2024-02-24T14:19:23Z","timestamp":1708784363000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0065128122001507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S0065128122001507"],"URL":"https:\/\/doi.org\/10.1016\/j.acthis.2022.151991","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.acthis.2023.151996","asserted-by":"object"}]},"ISSN":["0065-1281"],"issn-type":[{"value":"0065-1281","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Highly expressed FYN promotes the progression of placenta accreta by activating STAT3, p38, and JNK signaling pathways","name":"articletitle","label":"Article Title"},{"value":"Acta Histochemica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acthis.2022.151991","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"151991"}}